Targeting the Gut-Brain Axis - Pharmacologic and Nutritional Approaches in Psychosomatic GI Disorders

This chapter looks at the gut-brain axis, which is a bidirectional communication pathway that uses neurological, endocrine, and immunological mechanisms to link the gastrointestinal tract, intestinal microbiota, and central nervous system. The three major psychosomatic gastrointestinal disorders: irritable bowel syndrome (IBS), functional dyspepsia (FD), and functional constipation (FC), are caused by the dysregulation of this system. Recent research shows a strong correlation between psychiatric comorbidity in IBS patients and dysbiosis and dysregulated neurotransmitter metabolism, particularly regarding impaired serotonin and GABA production. Moreover, both gastrointestinal function and mood regulation are impacted in both directions by metabolites derived from microbes and modified vagal signaling. Nutritional approaches, including the use of strain-specific probiotics and low-FODMAP or Mediterranean diets, help restore microbial equilibrium and intestinal barrier function. Pharmacological interventions, such as tricyclic antidepressants (TCAs), modulate pain pathways and motility. Central dysregulation is addressed by psychological techniques such as stress management and cognitive behavioral therapy (CBT). Recent research shows that integrated treatment plans that incorporate psychological, nutritional, and pharmaceutical components result in better symptom relief than monotherapy. We conclude that interdisciplinary cooperation between gastroenterologists, psychiatrists, and nutritionists is necessary for optimal management. And that by addressing psychiatric comorbidity and underlying pathophysiology at the same time, this integrated approach improves quality of life and produces long-lasting symptom relief.